Physician profile
Gregory C Sweeney
NPI 1710955828
$6,442.89
in general payments reported to CMS, 2019-2025
36 companies · $1,429 in 2025
The $1,429 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $736 · 2020: $567 · 2021: $744 · 2022: $956 · 2023: $750 · 2024: $1,260 · 2025: $1,429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,439.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,452.76 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $717.83 | 2023-2025 | Caplyta |
| Novo Nordisk INC | $640.95 | 2019-2025 | Ozempic, Rybelsus |
| Lilly USA, LLC | $568.50 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $399.92 | 2019-2025 | Airsupra, Farxiga |
| Abbvie INC. | $392.99 | 2021-2025 | Ubrelvy, Qulipta, Viberzi |
| Amgen INC. | $213.57 | 2019-2025 | Repatha, Otezla, Krystexxa |
| Janssen Pharmaceuticals, INC | $191.87 | 2019-2023 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $183.24 | 2019-2025 | Xifaxan, Trulance |
| Pfizer INC. | $171.17 | 2020-2025 | |
| Phathom Pharmaceuticals, INC. | $165.05 | 2024-2025 | Voquezna |
| Philips North America LLC | $149.53 | 2020-2024 | (Ak6) Vest Therapy |
| Exact Sciences Corporation | $143.00 | 2025 | Cologuard Collection Kit |
| E.R. Squibb & Sons, L.L.C. | $131.26 | 2019-2025 | Eliquis, Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.41 | 2019-2025 | Jardiance |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $120.09 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $106.62 | 2019-2023 | Belsomra |
| Kowa Pharmaceuticals America, INC. | $102.46 | 2019-2022 | |
| Abbott Laboratories | $69.19 | 2021-2023 | Freestyle Libre 2 |
| Genzyme Corporation | $49.77 | 2023-2025 | |
| Biohaven Pharmaceuticals, INC. | $48.33 | 2021 | |
| Idorsia Pharmaceuticals US INC | $34.36 | 2023-2024 | Quviviq |
| Paratek Pharmaceuticals, INC. | $28.86 | 2022-2024 | Nuzyra |
| Biogen, INC. | $27.03 | 2021-2022 | |
| Astellas Pharma US INC | $25.17 | 2019 | |
| Esperion Therapeutics, INC. | $24.56 | 2020-2021 | |
| Genentech USA, INC. | $23.96 | 2021 | |
| Medtronic, INC. | $19.61 | 2024 | Intellis Adaptivestim |
| Otsuka America Pharmaceutical, INC. | $18.42 | 2024 | Rexulti |
| Bayer Healthcare Pharmaceuticals INC. | $17.35 | 2022 | |
| Lundbeck LLC | $15.59 | 2023 | Rexulti |
| Eisai INC. | $15.14 | 2021 | |
| Baxter Healthcare | $13.31 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $12.98 | 2021 | |
| Tactile Systems Technology INC | $12.14 | 2020 | |
| Allergan, INC. | $11.90 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Sweeney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.